San Jose, CA · Founded 2012 · Privately Held (backing)
Developer of polymerase chain reaction (PCR) based diagnostic testing devices designed for the detection of infectious diseases. Visby Medical is based in San Jose, CA and was founded in 2012. Its last reported valuation was $866 million in May 2020. It has raised $487 million across 1 recorded round; the latest was a $109 million later-stage round in Feb 2022.
Last reported valuation
$866.0M
Oct 2026
Priced at
—
Total raised
$486.6M
Last round
Later Stage VC
Feb 2022
No prints on record
No secondary trades in Visby Medical shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Visby Medical with a free account
·The complete investor list: 35 names
·Watch Visby Medical: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Visby Medical stock.
